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ABSTRACT. The nature of alloreactivity to MHC molecules has been enigmatic, primarily because of the observation 
that allogeneic responses are considerably stronger than syngeneic responses. To better determine the specificity 
potential of allogeneic responses, we have generated alloreactive CTL specific for exogenous, viral-derived peptide 
I igands. This approach allowed us to critically evaluate both the peptide- and MHC-specificity of these alloreactive 
T cells. Exploiting the accessibility of the H-2L d class I molecule for exogenous peptide ligands, alloreactive CTL 
were generated that are specific for either murine cytomegalovirus (MCMV) or Iymphocytic choriomeningitis virus 
(LCMV) peptides bound by Ld alloantigens. Peptide specificity was initially observed in bulk cultures of alloreactive 
CTL only when tested on peptide-sensitized T2.L d target cells that have defective presentation of endogenous 
peptides. Subsequent cloning of bulk alloreactive CTL Iines generated to MCMV yielded CTL clones that had 
exquisitely specific MCMV peptide recognition requirement. All of the MCMV!L d alloreactive CTL clones were also 
exquisitely MHC-specific in that none of the CTL clones Iysed targets expressing MCMV!L q complexes, even though 
L q differs from Ld by only six amino acid residues and L q also binds the MCMV peptide. This observation clearly 
demonstrates that alloreactive CTL are capable of the same degree of specificity for target cell recognition as are 
syngeneic CTL in MHC-restricted responses. Journal of Immunology, 1993, 151: 1. 
A g-specific, MHC-restricted CTL recognize a complex of peptide Ag presented in the context of self-MHC molecules; however, it remains un-
clear whether alloreactive CTL recognize MHC by a similar 
mechanism. Extensive studies in allorecognition have 
yielded several mechanistic models: 1) alloreactive CTL 
recognize only the foreign MHC in the absence of abound 
peptide, 2) alloreactive CTL recognize a conformational 
stabilization or change induced by abound peptide, thereby 
requiring the presence of peptide but not interacting directly 
with it, or 3) alloreactive CTL recognize and interact with 
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specific determinants on both the bound peptide as well as 
the allogeneic MHC molecule. The last model would sug-
gest that alloreactive CTL recognize alloantigens in a man-
ner analogous to recognition by Ag-specific, self-restricted 
CTL. 
Discrimination among these models has proven difficult. 
A study by Elliott and Eisen suggests that recognition of 
allogeneic MHC molecules can occur in the absence of 
bound peptide in that purified HLA-A2 molecules recon-
stituted in the absence of peptide could serve as an efficient 
recognition element for a CD8+ anti-A2 CTL line (1). 
However, the possibility that contaminating peptides re-
mained at low levels in the purified MHC preparation could 
not be excluded. 
The involvement of peptide in allorecognition has been 
demonstrated using the peptide transport-defective T2 cell 
line (2). Kb alloreactive CTL would only lyse T2.Kb target 
cells if they were pulsed with cyanogen bromide fragments 
of cytoplasmic proteins. Moreover, HPLC fractionation of 
the cleavage products revealed that individual clones were 
specific for different HPLC fractions. Similar peptide de-
2 
pendencies have been confinned by a number of other 
groups (3,4). Finally, a study by Rötzschke et al (5) pos-
tulates the existence of alloreactive CTL that can be 
grouped into three general categories: those that do not 
require peptide, those that require a specific peptide, and 
those for which different peptides appear to allow for rec-
ognition. Given the complexity of the reported data, it is 
possible that an alloresponse is the sum of a heterogeneous 
population of responding CTL that exhibit a spectrum of 
peptide requirements. However, the extent to which any 
specific type of alloreactive CTL contributes to the total 
allogeneic response is unknown. 
Previous studies have attempted to identify a role for 
peptide ligand in the recognition of allogeneic MHC, uti-
lizing alloreactive clones purportedly specific for an un-
known endogenous peptide ligand presented by alloanti-
gen. Identification of the peptide ligand specificity of these 
clones will likely be difficult given the large number of 
endogenous peptide Ag postulated to be presented by self-
MHC molecules. Furthennore, without identification ofthe 
peptide specificity of alloreactive CTL, it has been impos-
sible to investigate the separate contribution of MHC vs 
peptide detenninants. 
To more specifically address the involvement of peptide 
and MHC in aHorecognition, we have developed an assay 
system devised to generate alloreactive CTL to known 
peptide/MHC complexes. Interestingly, early studies by 
Ishii et al (6) suggested that alloreactive T cells specific for 
dass II MHC molecules could be generated to specific 
nominal Ag. In the present study CTL were generated to the 
alloantigen H -2L d in the presence of either the MCMV3 (7) 
or LCMV (8) peptide. L dis particularly well suited for these 
analyses because of the accessibility of its peptide binding 
site. Previous reports from our lab have demonstrated that 
L d can readily bind exogenous ligand as assessed by in-
creased cell surface expression after incubation with pep-
tide (9). The observed induction results from the stabili-
zation of L d molecules by significantly prolonging their 
surface half-life (10). Direct binding of exogenous peptides 
has been demonstrated and correlates with the observed 
induction in cell surface expression. 
Allogeneic responses to peptide/L d complexes were gen-
erated by stimulating splenocytes from the L d loss mutant 
strain dm2 (Kd+,Dd+, Ld-) with BALB/c (Kd+, Dd+, Ld+) 
splenocytes in the presence of either the MCMV or LCMV 
peptide. CTL lines generated against MCMV /L d or 
LCMV/Ld complexes lysed the c1ass I transport-defective 
cellline T2.L d only if pulsed with the appropriate peptide. 
When MCMV/Ld-specific alloreactive CTL were exam-
ined at the clonal level, astringent requirement for both 
peptide and MHC was observed. Therefore, we conc1ude 
3 Abbreviations used in this paper: MCMV, murine cytomegalovirus; LCMV, 
Iymphocytic choriomeningitis virus; dm2, L d·loss mutant mouse strain BALB/ 
c·H-2"m2 
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that alloreactive CTL exist that require specific peptide pre-
sented by alloantigen, and that these CTL recognize aHo-
geneic MHC in a manner analogous to that by which 
Ag-specific CTL recognize a foreign peptide presented by 
self-MHC. 
Materials and Methods 
Mice 
BALB/c Kh (H-2d) and BALB/c-H-2dm2 (dm2,Ld loss mu-
tant) mice were bred in the animal facility of Dr. Donald 
C. Shreffler, Washington University School of Medicine, 
St. Louis, Mo. BALB/c-H-2dm2 is derived from a BALB/c 
mouse that has deleted the L d gene (11). 
Peptides 
The amino acid sequence of the MCMV peptide corre-
sponds to residues 168-176 (YPHFMPTNL) ofthe MCMV 
immediate early protein pp89 (7). The amino acid sequence 
of the LCMV peptide corresponds to residues 119-127 
(RPQASGVYM) of the lymphocytic choriomeningitis vi-
rus protein (8). The tum- peptide contains amino acid res-
idues 12-24 (ISTQNHRALDLVA) of the mutant protein 
P91A- (exon 4) of the tum- P815 variant (12). Two iden-
tified endogenous L d -binding peptides were utilized, LSPF-
PFDL (13) and YPNVNIHNF (14). A ß-galactosidase 
derived peptide contains the amino acid residues TPH-
PARIGL(sequence from M. Bevan)_ Peptides were synthe-
sized using Merrifield's solid phase method (15) on a pep-
tide synthesizer (model 431A, Applied Biosystems, Inc, 
Foster City, CA). Peptides were purified (>90%) by 
reverse-phase HPLC and subjected to purity assessment 
techniques as previously described (16). 
Cell lines 
R l.l-L d was generated by introducing the L d gene into the 
Rl.1(H-2k ), a C58/J-derived thymoma cellline (ATCC# 
TIB 42) by electroporation and selection in G418 antibiotic. 
P8I5 is a DBA/2 (H_2d) derived mouse mastocytoma cell 
line (ATCC# TIB 64). L.Ld, L.LdL95I, L.LQHI55Y, 
K157R, L.L QHI55Y, and L.L q were generated by transfec-
tion of recombinant plasmids into DAP-3 L cells (U.H.K., 
manuscript in preparation). The T2 cellline is a somatic cell 
hybrid of human Band T lymphoblastoid cell lines that 
expresses low levels of HLA-A2 and undetectable levels of 
B5 at the cell surface (17). T2.L d was generated by e1ec-
troporation of T2 with the L d gene and was a gift of P. 
Cresswell (Yale University, New Haven, CT). RMA-S, a 
C57BL/6 derived thymoma (18,19), was the gift of J. Blue-
stone (University ofChicago, Chicago, IL). RMA-S.L d was 
generated by transfection of the H-2L d cDNA via lipofectin 
and selection in the presence ofO.6 mg/mI G418. Cells lines 
were maintained in RPMI 1640 (Gibco Laboratories, Grand 
Island, NY) supplemented with penicillin, streptomycin, 
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glutamine, HEPES and 10% FCS (Hyclone Laboratories, 
Logan, UT). 
Generation of in vitro primary alloreactive CTL 
5 X 106 Of 7.5 X 106 responding dm2 splenocytes were 
co-cultured with 3.5 X 106 irradiated (2.000 rads) BALB/c 
splenocytes + 10-4 M peptide (MCMV or LCMV) in 2 ml 
of sensitization medium per weH of a 24-well plate. On day 
5 of culture, effector cells were harvested, counted, and 
resuspended in RPMI 1640 supplemented with HEPES and 
10% new-bom bovine serum (Hyclone Laboratories, 
Logan, UT). 
Generation oi alloreactive CTL lines and clones 
CTL lines were established from primary cultures by re-
stimulation with 5 X 106 irradiated BALB/c splenocytes + 
10-5 M peptide (MCMV or LCMV) in 2 ml of sensitization 
medium per weIl of a 24-well plate. Subsequently, lines 
were restimulated under the same conditions with the ad-
dition of 10 Ulml rIL-2 (Biosource, Camarillo, CA). Sub-
clones were established by plating cells at various concen-
trations in round-bottomed microtiter plates in replicates of 
96. The weHs contained 1 X 106 irradiated BALBIc sple-
nocytes +1- peptide in 02 ml sensitization medium sup-
plemented with 10 U/ml rIL-2. After two additional in vitro 
restimulations, cells were tested for activity in a standard 
51Cr-release assay. Positive weHs were selected for expan-
sion based on the likelihood of clonality according to Pois-
son statistics (20). T2.L d cells incubated ovemight with 
10-4 M peptide or P8I5 cells were used as targets. Selected 
clones were maintained by weekly restimulation in 24-well 
plates as described above. 
51Cr release assay 
106 target cells were labeled for 1 h with 150-300 p.Ci of 
Na51 Cr04 (10-25 uCilml, Amersham Corp., Arlington 
Heights, IL) in 100 J.LI of RPMI-FCS with or without pep-
tide for 1 h at 37°C in 5% CO2. In some experiments eells 
were cultured ovemight with peptide before Iabeling. Cells 
were then washed and plated in 96-well round-bottomed 
microtiter plates. Effector cells were added at various eon-
centrations. Plates were spun at 50 g for 2 min and incu-
bated at 37°C and 5% CO2 for 4 h. 100 J.LI of supernatant 
was counted in an ISOMEDIC gamma counter (ICN Bio-
medicaIs, Huntsville, AL). The mean of triplicate sampies 
was calculated and percent SICr release was deterrnined 
according to the following equation: 
percent 51Cr release 100 
[ 
( experimental 51Cr release ) J control 51Cr release 
X 
(
maximum 51Cr release ) 
- control 51Cr release 
3 
where experimental SlCr release represents counts from tar-
get cells mixed with effector cells, control slCr release rep-
resents counts from target cells incubated in medium alone 
(spontaneous release), and maximum SICr release repre-
sents counts from target cells exposed to 5% Triton 
X-IOO. For the data presented in this paper, the SEM per-
cent specific lysis was <5% of the value of the mean. 
Generation of MCMV/RMA-S.L d alloreactive primary 
CTL 
7.5 X 106 C57BU6 splenocytes were cultured in the pres-
ence of 3.5 X 105 RMA-S.Ld cells (7,500 rad) in 2 ml of 
sensitization medium containing 10-4 M MCMV peptide 
per well of a 24-well plate. RMA-S.Ld cells had previously 
been cultured for 18 h at 25°C in the presence of 10-4 M 
MCMV peptide. On day 5 of culture, effector cells were 
harvested, counted, and resuspended in RPMI 1640 sup-
plemented with HEPES and 10% new-bom bovine calf 
serum. 
Results 
Peptide/L d-specific alloreactive CTL can be readily 
generated in the presence of exogenous peptide 
ligand 
In previous work from Dur lab, we demonstrated that L d 
surface expression is induced 3- to 4-fold after incubation 
with an L d peptide ligand (9). The induced moleeules pre-
sumably have bound the exogenous peptide, and therefore 
a high proportion of L d molecules contain the pulsed pep-
tide. The observed induction results from the stabilization 
of L d moleeules by significantly prolonging their surface 
half-life (10). Consistent with this notion, we are able to 
readily generate peptide-specific syngeneic CTL restricted 
by L d (21). We postulated, therefore, that peptide-pulsed L d 
moleeules may also provide an efficient system for gen-
erating peptide-specific alloreactive CTL. 
To this end, primary alloreactive CTL were generated in 
the L d loss mutant mouse strain drn2. Dm2 lymphocytes 
were stimulated with irradiated BALB/c(H-2d) splenocytes 
in the presence of either the MCMV or LCMV peptide 
during a 5-day in vitro culture. To enrich for peptide-
specific alloreactive CTL, primary cultures were restimu-
lated with H-2d splenocytes and peptide for 2 additional wk. 
To address the existence of peptide-specific L d alloreactive 
CTL in the lines, we utilized a target cell with increased 
sensitivity for identifying MCMV IL d or LCMV IL d-specific 
CTL. T2.L dis a peptide transport-defective cellline that has 
been transfected with the L d gene (17). Few class I mole-
cules are expressed on the surface of these cells and those 
that are appear to be either devoid of peptide or to contain 
low affinity peptides (22). In addition, incubation with an 
L d peptide ligand results in a significant increase in L d cell 
surface molecules, all of which have presumably bound the 
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FIGVRE 1. L d alloreactive lines generated in the presence of the MCMV or LCMV peptide are peptlue-specific. Responding 
dm2 splenocytes were co-cultured with irradiated BALB/c stimulators in the presence of 10-4 M MCMV or 10-4 M LCMV 
peptide. Cultures were restimulated with BAlB/c stimulators and 10-5 M peptide for 2 additional wk. At that time effector cells 
were harvested and cytotoxic activity assessed. Lines stimulated in the presence of MCMV(A) or LCMV(B) were tested for the 
ability to Iyse T2.Ld (e), T2.Ld +l0-4 M MCMV overnight(A), or T2.Ld +l0-4 M LCMV overnight(+). 
exogenous peptide. Thus, the relative absence of endoge-
nous peptidefL d complexes should result in a more homo-
geneous population of MCMV or LCMV peptidefL d com-
plexes compared with other peptide-induced target cells. In 
addition, because T2 is a human cell line, it is less likely 
that endogenous peptides presented by L d on these cells 
would be recognized by alloreactive CTL generated by 
stimulation with murine splenocytes. Together, these at-
tributes should afford increased sensitivity for these target 
cells in identifying peptide-specific alloreactive CTL in the 
lines generated in the presence of peptide. 
Indeed, the peptidefLd alloreactive lines demonstrated 
exquisite specificity in their lysis of peptide-induced T2.L d 
cells. Figure 1 shows that CTL stimulated with MCMV fL d 
lysed T2.Ld cells induced with the MCMV peptide, but did 
not Iyse T2.Ld incubated with the LCMV peptide even 
though this peptide induced equivalent levels of L d surface 
expression (data not shown). Similarly, CTL stimulated 
with LCMV fL d specifically lysed only LCMV-induced 
T2.L d target cells (Fig. 1). Therefore, it is evident that 
peptide-specific alloreactive CTL can readily be generated 
via stimulation in the presence of L d peptide ligand. It is 
noteworthy, however, that these lines recognized R 1.1-L d 
(H-2d) target cells very efficiently in the absence of peptide 
pulsing. In addition, no increase in the lysis of R 1.1-L d cells 
optimally induced with the generating peptide was ob-
served (Fig. 2). Preferentiallysis of peptide-induced target 
cells may have been expected as a result of recognition by 
the peptide-specific component within the alloreactive CTL 
lines. The requirement of the alloreactive lines for the ap-
propriate peptide for T2.L d lysis, together with the obser-
vation that lysis of R l.l-L d cells is independent of peptide 
pulsing, suggested that either 1) separate subpopulations 
existed within the lines, those that recognized endogenous 
peptides presented by L d and those specific for the gener-
ating peptide presented by Ld ; or 2) a cross-reaction existed 
between the MCMV or LCMV peptide and endogenous 
peptides presented by Rl.l-Ld • To distinguish between 
these two possibilities, clones were generated from the 
MCMVfLd CTL line and evaluated for their peptide 
requirements. 
Alloreactive MCMV/l d CTl clones demonstrate 
exquisite peptide specificity 
To investigate the existence of two subpopulations within 
the lines, CTL were cloned from the MCMV IL d alloreac-
tive line. Initial clonings were carried out in the presence 
of MCMV peptide and MCMV-specific alloreactive CTL 
clones were identified based on their ability to lyse MCMV-
pulsed T2.L d target cells. In an independent cloning, CTL 
were cloned in the absence of MCMV peptide and clones 
were chosen based on positive lysis of P815 (H-2d ) cells. 
The latter cloning was designed to specifically identify 
clones capable of recognizing L d independent of the 
MCMV peptide. CTL clones of two distinct specificities 
were obtained: those that required the MCMV peptide far 
Ld recognition and those that recognized Ld in the absence 
of the MCMV peptide. 
Clones obtained as a result of stimulation with L d in the 
absence of MCMV peptide efficiently lysed non-MCMV 
pulsed P815 target cells. It is likely that these clones ac-
count for the MCMV-independent lysis observed in the al-
loreactive CTL lines generated in the presence of peptide. 
Although we have not directly investigated the peptide re-
quirement of these clones, we feel that they are likely to 
require the presentation of an endogenous peptide based on 
their inability to lyse T2.L d cells. This observation suggests 
a requirement for the presence of a murine-specific peptide 
present on P815 but missing on T2.Ld . 
From two clonings carried out in the presence of MCMV, 
seventeen clones were obtained. The MCMV specificity of 
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FIGURE 2. Alloreactive CTL lines generated to peptideil d complexes do not preferentially recognize Rl.l-L d targets induced 
with the stimulating peptide. Alloreactive lines generated as described in Figure 1 were tested for the ability to discriminate 
peptide presented by Rl.l-L d. Lines generated in the presence of (A)MCMV or (B)LCMV peptide were examined for lysis of 
untreated Rl.l or Rl.l-Ld cells or Rl.l-L d cells induced overnight with 10-4 M MCMV or 10-4 M LCMV peptide before the 
assay. 
the clones was established by demonstrating the ability to 
discriminate among a variety of L d peptide ligands, includ-
ing viral, tumor-specific, bacterial, and recently defined en-
dogenous peptides. P8I5 cells pulsed with MCMV, LCMV, 
tum-, ß-gal, ENDO I, or ENDO II (Materials and Methods) 
were used as targets for the alloreactive MCMV/Ld CTL 
clones. All MCMV /L d clones analyzed displayed an ab-
solute requirement for the MCMV peptide. Two represen-
tative clones are shown in Figure 3. All peptides utilized in 
this analysis induce equivalent levels ofLd surface expres-
sion (23 and data not shown); thus the ability of clones to 
distinguish among the peptides could not result from dif-
ferences in the number of allogeneic L d determinants, but 
would reflect a specific peptide requirement. In addition, 
the inability of these clones to recognize P815 (Fig. 3) or 
R l.1-L d cells (Fig. 4) in the absence of MCMV peptide 
suggests that they cannot recognize any endogenous pep-
tide presented by L d. It is noteworthy that the MCMV /L d 
clones were capable of efficiently lysing targets pulsed for 
I h with 10-8_10- 10 M peptide. These determinant density 
requirements are similar to those observed for Ag-specific, 
self-restricted CTL (21) and imply that peptide-specific al-
loreactive and MHC-restricted CTL are not inherently dif-
ferent in their peptide recognition requirements. 
Alloreactive MCMV!L d CH clones demonstrate 
exquisite MHC specificity 
The necessity for presentation of the MCMV peptide by L d 
was examined by evaluating the ability of the MCMV /L d 
alloreactive CTL clones to recognize MCMV presented by 
the H-2L q molecule. The L d and L q dass I molecules differ 
at only six amino acid positions: 95, 97, 107, 116, 155, and 
157 (24). Both molecules bind MCMV to a significant de-
gree (9) and present this peptide physiologically after 
A Clone 2.11.2 
B 
Clone 2.12.4 
60 80 
CD 60 CI) 
: 40 A_A_A A_A ........ A ~ \ \ .I:! 40 ~ CD 
c% 20 
-s. 20 
0 
i_.s!~ 0 
10 5 2.5 10 5 2.5 
E:T E:T 
FIGURE 3_ Alloreactive MCMV/Ld-specific clones demon-
strate an absolute dependence on the presence of the MCMV 
peptide. Two representative clones are shown. Target cells 
are p8l5(e) or P8l5 pulsed for 1 h with a variety of peptide 
ligands; P8l5+MCMV(.), P8l5+LCMV(.), P8l5+tum--
(_j, P8l5+ß-gal(D), P8l5+ENDO I(ß), P8l5+ENDO 11(0). 
MCMV infection (25). In addition, the Rl.1-Ld and Rl. 
l-L q transfected cells used as targets in this assay express 
very high and comparable levels of their respecti ve L mole-
cules (data not shown). All 17 alloreactive MCMV/L d CTL 
clones examined demonstrated an absolute requirement 
for MCMV presentation by the Ld molecule, exhibiting 
no cross-reactive lysis on MCMV-pulsed L q target cells 
(Fig. 4). This discrimination between Ld and Lq implies 
that, in addition to peptide, these MCMV /L d alloreactive 
CTL require either direct or indirect recognition of MHC 
determinants. To investigate the contribution of individual 
MHC residues in recognition by the MCMV /L d alloreactive 
clones, we utilized mutant molecules representing inter-
mediates between L d and L q. Mutants chosen for study pos-
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FIGURE 4. Alloreactive MCMV/L d-specific clones recog-
nize MCMV presented by H-2L d but not by H-2L q. The MHC 
specificity of the MCMV!L d clones was demonstrated by their 
ability to discriminate presentation by L d versus L q. The cy-
tolytic activity of two representative clones is shown. Targets 
were pulsed for 1 h with 10-4 M MCMV peptide. R1.1-
Ld+MCMV(.l, R1.1-Ld(e), R1.1-Lq+MCMV(Al, Rl.l-Lq(+). 
sessed substitutions at position 155 (L qHI55Y), 155 and 
157 (LqHI55Y,KI57R), or 95 (LdL95I). Importantly, pa-
rental and variant L d/L q moleeules were expressed at high 
levels, and eaeh retained the ability to bind the MCMV 
peptide as determined by a two-fold or greater induetion of 
L d eell surfaee expression by FACS analysis after ineuba-
tion with peptide (data not shown). Mutants with substi-
tutions at positions 155 and 157 were seleeted beeause 155 
and 157 are the only two positions that differ within the 
alpha helical regions of L d and L q. It is these regions of 
the MHC mole eule that are postulated to interaet direetly 
with the TCR (26) and therefore are likely to be critieal for 
reeognition. 
As previously demonstrated, the clones do not recognize 
MCMV presented by L q; however, substitutions of the 
amino acid residues at positions 155 and 157 in L q (L. 
L qHI55Y,KI57R) with those found in L d rendered this mu-
tant moleeule susceptible to lysis after pulsing with the 
MCMV peptide (Fig. 5). Interestingly, mutant L.LQH155Y 
was recognized by clones as efficiently as L.LQH155Y, 
K157R (Fig. 5). Thus position 155 appears to be critieal for 
reeognition of L d by these clones. The involvement of 
residues at position 155 in allorecognition has been iden-
tified by others (27-29). Henee, this position may be eom-
monly used in reeognition of MHC by alloreaetive CTL. 
Although MCMV /L d CTL clones eould reeognize both 
L.LQHI55Y,RI57K and L.LQHI55Y, reeognition of these 
mutant moleeules was less efficient than reeognition of the 
wild type. Even the use of targets maximally indueed with 
peptide before the assay and the presence of continuous 
peptide during the assay did not allow for recognition at 
levels equivalent to wild type (data not shown). Therefore 
interaetion of the TCR with residues in the a helices is not, 
by itself, sufficient for maximal recognition. Consequently, 
we investigated the contribution of residues within the 
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ß-pleated sheet of the MHC moleeule. 
Residues within the ß-pleated sheet of the MHC mole-
eule are suggested to be involved in ligand binding (26). 
When tested, mutant L.L dL95I was reeognized by the al-
loreaetive MCMV /L d CTL clones, although at a redueed 
level compared with the wild type L d moleeule (Fig. 5) . 
When assayed by FACS analysis, these two moleeules have 
similar basal levels of L d expression and ean be indueed 
3-to 5-fold after incubation with the MCMV peptide (data 
not shown), thus demonstrating that both moleeules are 
eapable of effieiently binding the MCMV peptide. The fail-
ure of the helical substitutions to fully restore reeognition, 
and the suboptimal reeognition of L.L dL95I, is eonsistent 
with the notion that residues within the ß-pleated sheet 
position the peptide. Consequently, it is possible that dif-
ferences in peptide positioning eould influence CTL rec-
ognition. Maryanski et al and Hunt et al (29, 30) have dem-
onstrated the contribution of residues within the ß-pleated 
sheet on recognition by a110reaetive CTL. However, the 
influenee of these residues on the bound peptides could not 
be monitored in these systems. In any ease the faet that the 
MCMV/Ld alloreactive CTL were generated to a known 
peptide permitted us the unique opportunity to evaluate 
their MHC specifieity apart from their peptide require-
ments. Furthermore, the demonstration that these allore-
active CTL have a precise peptide and MHC specificity 
suggests that allorecognition is mechanistically similar to 
self-restricted recognition of foreign peptide Ag. 
Primary alloreactive MCMV/ld CTl can be efficiently 
generated when stimulated with MCMV-induced 
RMA-S.l d cells 
Because the peptide transport mutant T2.L d permiued pep-
tide discrimination at the target eellievel, we postulated that 
it mayaiso serve as a proficient stimulator for MCMV-
specific alloreaetive CTL in a primary response. However, 
Ouf attempts to stimulate a primary response with the T2.L d 
eellline were ineffective. Alternatively, we transfected L d 
into the RMA-S cell line. RMA-S, like T2, is a transport-
defeetive eell line and is advantageous for this study be-
cause of the deereased level of endogenous peptide pre-
sentation. In addition, it is a murine eellline and therefore 
should possess the appropriate accessory molecules that 
may be required for effieient stimulation of naive T eells. 
C57BL/6 (H-2b ) splenoeytes were stimulated with 
RMA-S.Ld eells that had previously been ineubated with 
10-4 M MCMV for 18 h at 25°C. After the 5-day eulture 
period, responder cells were assayed for their ability to 
diseriminate presentation of the MCMV peptide. Figure 6 
shows that alloreactive MCMV /L d-specific CTL can be de-
tected in a primary bulk eulture response as demonstrated 
by the preferentiallysis of RMA-S.L d target cells indueed 
with the MCMV peptide. In a11 experiments primary CTL 
generated in the presence of MCMV lysed MCMV-indueed 
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FIGURE 5. Recognition of L cl and L q 
mutants by MCMV!L cl-speeifie clones. 
Top: View of the antigenie groove of L d. 
The loeation of amino aeid positions 
that differ between L d and L q are indi-
eated. Differenees are given as residue 
position:L cl amino aeid:L q amino acid-
95:L:1, 97:W:R, 107:G:W, 116:F:Y, 755: 
7 
Clone 2.8.2 
Y:H, 757:R:K. Bottom: A panel of mu-
tants expressing intermediates between 
L cl and L q was used to assess residues 
important for recognition by the clones. 
Targets were pulsed for 1 h with 10-4 M 
MCMV peptide: L.Ld(.); L.LdL951(D); 
L.L qH155Y,K157R(.); L.L qH155Y(A); 
and L.L q(e). Mutant and wild type 
moleeules were expressed at high levels 
on the cells surface. In addition, all tar-
gets were eapable of binding the MCMV 
peptide as demonstrated by induetion af-
ter incubation with MCMV peptide. 
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RMA-S.L d at levels significantly above noninduced RMA-
S.L d cells. Thus using cells such as RMA-S as stimulators 
may be the most direct way to generate alloreactive CTL 
populations with specificity for a given peptide. 
In addition to the ability to detect MCMV /L d-specific 
CTL in RMA-S.Ld-stimulated primary responses. initial 
studies show that MCMV /L d -specific alloreactive CTL pre-
cursors can be detected under conditions of limiting dilu-
tion (data not shown). Stimulation with BALB!c spIe no-
cytes in the presence of MCMV peptide was sufficient to 
elicit the MCMV/Ld-specific precursors. Their detection in 
limiting dilution analyses as weIl as in primary responses 
(Fig. 6) suggests that MCMV /L d-specific alloreactive CTL 
are not rare clones, but rather represent a readily detectable 
component of the repertoire of alloreactive CTL. 
Discussion 
This study clearly demonstrates the existence of peptide-
specific alloreactive CTL. It is the first example of the gen-
40 20 10 5 
E:T 
eration of alloreactive CTL to a known peptide/allogeneic 
MHC complex. This allowed us the unique opportunity to 
address the role of defined peptides in the recognition of 
allogeneic MHC, as weIl as to discriminate between 
peptide-dependent versus peptide-specific recognition by 
these alloreactive CTL. Other studies, although demon-
strating a role for peptide Ag, have relied on the use of al-
loreactive clones presumably generated to endogenous 
peptide/class I complexes (2-5, 31, 32). The involvement 
of peptide ligand has been demonstrated via addition of cy-
anogen bromide-derived peptides of cytoplasmic proteins 
(2), or by blocking recognition through the addition of ex-
ogenous peptides (31, 32). These studies, although demon-
strating a dependence on peptide ligand, do not address 
whether these CTL require a specific peptide or whether 
any peptide (or group of peptides) will suffice. Knowledge 
of the peptide ligand for which our alloreactive CTL are 
specific allows us not only to demonstrate peptide involve-
ment in recognition, but to establish the monospecificity of 
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FIGURE 6. MCMV/Ld-specific CTL are readily detectable 
in an alloreactive primary bulk culture. C57BL/6 splenocytes 
were  co-cultured in the  continuous  presence of M 
MCMV peptide with RMA-S.Ld cells  previously  induced  with 
M MCMV at 25°C. On day 5, effector  cells  were  har- 
vested  and  tested for recognition of RMA-S or RMA-S.Ld cells 
incubated at 25°C  overnight  or RMA-S.Ld cells  induced  over- 
night at  25°C in the presence of M MCMV or M 
LCMV peptide. 
the peptide requirement. This system is also the first in 
which the separate contribution of allogeneic MHC versus 
bound peptide can be addressed. 
Other than the current study, the peptide ligand has been 
identified for only two alloreactive clones. An endogenous 
peptide ligand was recently identified for the well charac- 
terized 2C alloreactive Ld clone (13). Additionally a viral 
peptide, presumably cross-reactive with the endogenous 
peptide to which  the clone was originally generated, was 
identified that would  allow recognition of RMA-S cells by 
a Kb-specific alloreactive clone (33). This result differs 
from ours, however,  in  that  we did not identify any clones 
generated to  the viral peptide MCMV that were capable of 
cross-reacting with  an endogenous peptide presented by Ld 
(discussed below). 
Although we have demonstrated peptide-specific recog- 
nition in our system, we cannot exclude the existence of 
alloreactive CTL with very different recognition require- 
ments. A study by Rotzschke et a1 (5 )  identified CTL with 
a variety of peptide requirements including CTL that rec- 
ognize RMA-S cells induced  at  25°C. These results suggest 
that alloreactive CTL may exist that are capable of recog- 
nizing empty MHC molecules. However, the ability of 
RMA-S cells to present endogenous molecules has been 
demonstrated by this group as well as others (34,35). There- 
fore, as stated by the authors, positive lysis is not assurance 
of recognition of empty molecules. Additionally, this group 
identified a line that recognized a range of peptides pre- 
sented by Kb. However,  as  noted by the authors, this line 
may  be polyclonal, as was our MCMV/Ld line, and there- 
fore the existence of such a population remains unclear. If 
indeed peptide cross-reactive CTL exist, such a promiscu- 
ous peptide requirement could result from recognition of 
similar MHC conformational changes induced by peptide 
binding. Several families of peptides may exist that yield 
alternative MHC conformations upon binding (36, 37). 
When analyzed by cytolysis assays, it would appear that a 
given clone was capable of recognizing multiple peptides 
bound by the same MHC molecule, when in actuality only 
conformational determinants on the MHC were  being di- 
rectly recognized. In our analysis we did not identify any 
clones that displayed promiscuity in their peptide require- 
ment,  based on the following criterion. Given the complex 
array of endogenous peptides that are likely presented 
by Ld (38), it seems probable that the pool of endo- 
genous peptides would encompass all of the possible 
conformation-inducing families, including a putative fam- 
ily  to  which  MCMV  would belong. Therefore lysis of non- 
pulsed targets by the MCMV/Ld-specific clones would 
have been observed. In no case did we identify clones ca- 
pable of lysing both  MCMV-pulsed T2.Ld targets and non- 
pulsed wild type Ld-expressing target cells. Although we 
cannot exclude the possibility of the existence of such al- 
loreactive CTL, we feel it is unlikely  that conformationally 
restricted CTL are a dominant portion of the alloresponse 
described in  this  study. 
One of the central questions that has intrigued those 
studying allorecognition has  been the vigorous in vitro pri- 
mary response to alloantigens. Early studies demonstrated 
that the potency of the response was in part a result of a high 
frequency of alloantigen-specific precursors compared 
with peptide-specific, self-restricted precursors (39,40). To 
explain the high frequency of alloantigen-specific precur- 
sors, an initial model proposed a requirement for recogni- 
tion of residues exclusively within the MHC molecule (41). 
Thus every allogeneic MHC molecule could serve as an 
efficient recognition element for a responding alloreactive 
CTL. The resulting high determinant density would allow 
CTL displaying a wide range of affinities, i.e. those re- 
quiring few allogeneic MHC interactions, as well as those 
requiring many, to be effectively recruited. If indeed de- 
terminant density is not a limiting factor, then  most, if not 
all, alloreactive CTL capable of responding would  be ac- 
tivated, resulting in the high number of alloreactive CTL 
observed. 
Our results suggest a high precursor frequency via an 
alternative model. Although this model has previously been 
postulated (42), only recently has methodology been de- 
veloped that makes it readily testable. Recent data suggests 
that cells normally present a large number of distinct en- 
dogenous peptides complexed with self-MHC (38). If one 
proposes that a majority of these peptides are presented at 
levels capable of activating naive CTL, then CTL precur- 
sors of many different peptide specificities would  be elic- 
ited during the course of a normal alloresponse. Therefore 
a high number of precursor CTL would  be observed that 
were capable of responding to a given allogeneic MHC; 
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however, their individual peptidelMHC specificities would 
likely vary extensively. The ability to readily generate 
peptide-specific alloreactive MCMV /I} and LCMV /L d 
CTL strongly supports this model. 
In summary we describe the generation of alloreactive 
CTL that are exquisitely peptide- and MHC-specific. It is 
noteworthy that the MCMV/Ld-specific alloreactive CTL 
could be generated from T cells selected from either the 
dm2 (H_2dm2) or CS7BU6 (H_2b) background. Neither en-
dogenous peptides presented by L d nor a panel of exoge-
nous L d peptide ligands could substitute for the MCMV 
peptide and allow for recognition by our MCMV/Ld al-
loreactive CTL clones. Additionally, the clones demon-
strated apreeise requirement for MCMV presentation by L d 
as presentation by L q was insufficient for recognition. Fur-
thermore, the ability of our system to detect the differential 
contribution of peptide versus MHC in allorecognition 
demonstrates that residues within in the (l helices as wen 
as the ß-pleated sheet are important for maximizing the 
efficiency of alloantigen recognition. This system is unique 
in that it can be utilized for the analysis of responses to the 
same peptide presented in the context of either seIf or for-
eign MHC molecules. Thus direct comparisons can be 
made to define the precise manner by which syngeneic ver-
sus allogeneic CTL interact with MHC/peptide complexes. 
This information may help in defining the details of aI-
loreactive T lymphocyte generation as a consequence of 
positive and negative selection on self-MHC molecules. 
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